China’s Ministry of Commerce announces new restrictions for the export of rare earth metals.
Israel and Hamas agree to new ceasefire deal after extensive negotiations in Egypt.
The beverage industry’s new health campaign pushes choice and transparency, but behind the buzzwords is a strategy to avoid regulation.
Louisiana sues the FDA over abortion pills by mail, testing the limits of state power, federal oversight, and legal grey areas.
Claims of an FBI unit spying on GOP senators reignite debate over political bias, surveillance reform, and Americans’ trust in federal power.
French Prime Minister Sebastian Lecornu resigns, throwing France into a political crisis.
Gold breaks $4,000 amid global unrest and market anxiety, signaling investor caution and raising new questions about economic stability.
Trump Administration’s federalization of National Guard troops in several U.S. cities faces legal hurdles.
The Supreme Court’s debate over ‘conversion therapy’ bans could reshape how far free speech reaches into professional counseling and state regulation.
A post-pandemic standoff over health subsidies shows a divided nation still wrestling with how much government help should stay in place.
Israel marks the two-year anniversary of the October 7th attacks by Hamas, which started the Gaza war.
Sales for Chinese electric vehicle maker BYD jumped 880% in Britain for the month of September.
